1. Home
  2. Search
  3. Results
  4. » فارسی
» Advanced search
Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 1-1 of 1 results.
 
{{ selectedCountPage }} items selected on this page, {{ selectedCountPage }} item selected on this page, {{ selectedCountTotal }} item in total {{ selectedCountTotal }} items in total
Buspirone VS ritaline in the treatment of ADHD: a randomized clinical trial
The aim of the present study is to evaluate the efficacy of Buspirone on ADHD in children and adolescents through a double-blind, randomized, controlled trial. 40 outpatients, including 6-17 years old who clearly meet the DSM-IV-TR diagnostic criteria for ADHD will be randomly assigned to receive Buspirone tablets (20mg/day) or methylphenidate (20 mg/day for those who are <30 Kg and 30 mg/day for those who are >30 Kg) for 6 weeks. The primary outcome measure is the Teacher and Parent ADHD Rating Scale- IV. Patients will be assessed at baseline as well as 3 and 6 weeks after the medication started.
IRCTID: IRCT201011101556N17
  1. comparison of bupropion and ritaline in the treatment of children with ADHD: a double blind trial
  2. Comparing the efficacy of Agomelatine and Ritaline in treating children with ADHD in a randomized double-blinded clinical trial
  3. L Carnosine added to ritaline in the treatment of ADHD: A double blind and placebo controlled trial
  4. Ginkgo biloba in the treatment of ADHD in child and adolescent: a randomized clinical trial
  5. Saffron versus Methylphenidate in the treatment of Attention Deficit/ Hyperactivity Disorder: a double-blind and randomized trial
  6. Buspirone versus Methylphenidate in the treatment of Attention Deficit Hyperactivity Disorder: a double-blind and randomized trial
  7. The effectiveness of omega-3 supplement as an adjunctive therapy in children with attention deficit hyperactivity disorder
  8. Buspirone versus Methylphenidate in 6-16 aged children with Attention Deficit/Hyperactive Disorder(ADHD). A crossover study
  9. Efficacy of bupropion for attention deficit hyperactivity disorder in adults: a double blind and placebo controlled trial
  10. Double-blind randomized comparison of efficacy and side effects of Bupropion versus methyl phenidate in children with Attention Deficit Hyperactivity Disorder (ADHD)
Loading...